A detailed history of Metis Global Partners, LLC transactions in Danaher Corp stock. As of the latest transaction made, Metis Global Partners, LLC holds 40,323 shares of DHR stock, worth $9.42 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares
40,323
Previous 41,856 3.66%
Holding current value
$9.42 Million
Previous $10.5 Million 7.19%
% of portfolio
0.36%
Previous 0.36%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$239.25 - $280.76 $366,770 - $430,405
-1,533 Reduced 3.66%
40,323 $11.2 Million
Q2 2024

Aug 06, 2024

BUY
$235.51 - $267.98 $145,074 - $165,075
616 Added 1.49%
41,856 $10.5 Million
Q1 2024

May 06, 2024

BUY
$224.58 - $256.19 $88,933 - $101,451
396 Added 0.97%
41,240 $10.3 Million
Q4 2023

Feb 06, 2024

BUY
$185.1 - $233.13 $1.02 Million - $1.29 Million
5,512 Added 15.6%
40,844 $9.45 Million
Q3 2023

Nov 07, 2023

BUY
$233.08 - $265.59 $1.04 Million - $1.19 Million
4,481 Added 14.52%
35,332 $8.77 Million
Q2 2023

Aug 07, 2023

BUY
$224.99 - $256.14 $320,385 - $364,743
1,424 Added 4.84%
30,851 $7.4 Million
Q1 2023

May 08, 2023

BUY
$239.75 - $277.0 $1.51 Million - $1.74 Million
6,299 Added 27.24%
29,427 $7.42 Million
Q4 2022

Feb 07, 2023

BUY
$241.42 - $282.29 $2.4 Million - $2.81 Million
9,951 Added 75.52%
23,128 $6.14 Million
Q3 2022

Nov 08, 2022

BUY
$247.06 - $1507.4 $401,472 - $2.45 Million
1,625 Added 14.07%
13,177 $3.4 Million
Q2 2022

Aug 08, 2022

BUY
$237.11 - $299.66 $349,263 - $441,399
1,473 Added 14.61%
11,552 $2.93 Million
Q1 2022

May 03, 2022

BUY
$257.27 - $315.76 $1.15 Million - $1.41 Million
4,452 Added 79.12%
10,079 $2.96 Million
Q4 2021

Feb 11, 2022

BUY
$292.08 - $329.01 $1.64 Million - $1.85 Million
5,627 New
5,627 $1.85 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $170B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Metis Global Partners, LLC Portfolio

Follow Metis Global Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Metis Global Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Metis Global Partners, LLC with notifications on news.